Brii Biosciences Limited (HKG:2137)

Brii Biosciences Revenue

Brii Biosciences had revenue of 27.78M CNY in the half year ending December 31, 2024, a decrease of -70.57%. This brings the company's revenue in the last twelve months to 122.73M, up 219.77% year-over-year. In the year 2024, Brii Biosciences had annual revenue of 49.94M, down -10.65%.

• Revenue (ttm): 122.73M CNY
• Revenue Growth: +219.77%
• P/S Ratio: 10.86
• Revenue / Employee: 1.25M CNY
• Employees: 98
• Market Cap: 1.46B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	49.94M	-5.96M	-10.65%
Dec 31, 2023	55.89M	-66.39M	-54.29%
Dec 31, 2022	122.28M	29.74M	32.13%
Dec 31, 2021	92.54M	10.32M	12.56%
Dec 31, 2020	82.22M	62.02M	307.10%